Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To research drug patent expirations and NCE dates
— Patent attorney, USA
To know the expiration dates of patents
— Regulatory affairs services, Brazil
For drug patent information on drugs not available in Asia
— Pharmaceutical distribution, Singapore
To know patent expirations 8-15 years from now and formulation information
— Generic drug importer, Japan
To get nformation about pending patent expiries in the pharmaceutical market
— Sales, Sweden
Generated: May 27, 2017
| Patents: | 14 |
| Tradenames: | 27 |
| Ingredients: | 19 |
| NDAs: | 31 |
| Drug Master File Entries: (click here to view) | 137 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt Inc | OXYMORPHONE HYDROCHLORIDE | oxymorphone hydrochloride | TABLET;ORAL | 202321-002 | Apr 25, 2013 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mallinckrodt Inc | RESTORIL | temazepam | CAPSULE;ORAL | 018163-003 | Oct 25, 1991 | AB | RX | Yes | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mallinckrodt Inc | XARTEMIS XR | acetaminophen; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204031-001 | Mar 11, 2014 | RX | Yes | Yes | 9,468,636 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mallinckrodt Inc | METHYLIN ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 075629-001 | May 9, 2000 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Mallinckrodt Inc | TOFRANIL | imipramine hydrochloride | TABLET;ORAL | 087846-001 | May 22, 1984 | AB | RX | No | Yes | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To study drug patents and develop plans to synthesize molecules without infringing their patents
— Asst R&D manager, UK
To gain information on when to expect generics on the market in order to inform patients of when they can expect more affordable drugs
— Retail pharmacist, USA
To get information about drug synthesis
— Chemical research, Spain
To get information on patent expiration dates, in particular composition patents
— Private equity, USA
To get patent expiration dates for several products
— Industrial pharmacist, India
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
